4-(2-methoxy-3-nitrophenyl)-1-(trifluoroacetyl)piperidine | 648902-56-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-(2-methoxy-3-nitrophenyl)-1-(trifluoroacetyl)piperidine
• 英文别名: 2,2,2-Trifluoro-1-[4-(2-methoxy-3-nitrophenyl)piperidin-1-yl]ethan-1-one；2,2,2-trifluoro-1-[4-(2-methoxy-3-nitrophenyl)piperidin-1-yl]ethanone
• CAS: 648902-56-1
• 化学式: C₁₄H₁₅F₃N₂O₄
• 分子量: 332.279
• InChiKey: BCIBGZJKKVVWDV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  75.4
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2,2,2-三氟-1-[4-(2-甲氧基-苯基)哌啶-1-基]乙酮 在 硝酸 、 乙酸酐 、 sodium hydroxide 、 sodium carbonate 作用下， 以 水 为溶剂， 反应 0.5h， 以54%的产率得到4-(2-methoxy-5-nitrophenyl)-1-(trifluoroacetyl)piperidine
  参考文献：
  名称：

  [EN] SUBSTITUTED BENZANILIDES AS MODULATORS OF THE CCR5 RECEPTOR
  [FR] BENZANILIDES SUBSTITUES UTILISES EN TANT QUE MODULATEURS DU RECEPTEUR CCR5

  摘要：

  公开号：

  WO2004011427A3

文献信息

• PIPERIDINES AND PYRROLIDINES
  申请人：MERCK PATENT GmbH

  公开号：EP0898569A1

  公开（公告）日：1999-03-03
• [EN] PIPERIDINES AND PYRROLIDINES<br/>[FR] PIPERIDINES ET PYRROLIDINES
  申请人：MERCK PATENT GMBH

  公开号：WO1997040038A1

  公开（公告）日：1997-10-30

  (EN) The invention relates to novel piperidine and pyrrolidine derivatives of formula (I) in which R1, R2, R3, k, l, m and n have the meanings indicated in Claim 1, and their salts, novel intermediates and processes for the preparation of the compounds according to the invention. The compounds of formula (I) act as 5-HT1A receptor antagonists and exhibit 5-HT reuptake-inhibiting actions and can be used for the production of medicaments.(FR) L'invention se rapporte à de nouveaux dérivés de pipéridine et pyrrolidine de la formule (I) dans laquelle R1, R2, R3, k, l, m et n ont les significations reportées dans la revendication 1, et à leurs sels. L'invention se rapporte également à de nouveaux intermédiaires et aux processus de préparation de ces composés. Les composés de la formule (I) font office d'antagonistes du récepteur 5-HT1A, ils présentent des actions inhibitrices du recaptage de 5-HT, et peuvent être utilisés dans la fabrication de médicaments.
• [EN] SUBSTITUTED BENZANILIDES AS MODULATORS OF THE CCR5 RECEPTOR<br/>[FR] BENZANILIDES SUBSTITUES UTILISES COMME MODULATEURS DU RECEPTEUR CCR5
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2004010943A2

  公开（公告）日：2004-02-05

  This invention relates to substituted benzanilides which are modulators, agonists or antagonists, of the CCR5 receptor. In addition, this invention relates to the treatment and prevention of disease states mediated by CCR5, including, but not limited to, asthma and atopic disorders (for example, atopic dermatitis and allergies), rheumatoid arthritis, sarcoidosis and other fibrotic diseases, atherosclerosis, psoriasis, autoimmune diseases such as multiple sclerosis, and inflammatory bowel disease, all in mammals, by the use of substituted benzanilides which are CCR5 receptor antagonists. Furthermore, since CD8+ T cells have been implicated in COPD, CCR5 may play a role in their recruitment and therefore antagonists to CCR5 could provide potential therapeutic in the treatment of COPD. Also, since CCR5 is a co-receptor for the entry of HIV into cells, selective receptor modulators may be useful in the treatment of HIV infection.
• [EN] SUBSTITUTED BENZANILIDES AS MODULATORS OF THE CCR5 RECEPTOR<br/>[FR] BENZANILIDES SUBSTITUES UTILISES EN TANT QUE MODULATEURS DU RECEPTEUR CCR5
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2004011427A3

  公开（公告）日：2005-02-03